Clean Coal Technology Global Market 2018 Key Players,Share, Trend, Segmentation And Forecast To 2025

Market Analysis Research Report On Global Clean Coal Technology Market 2018 Industry Growth, Size, Trends, Share And Forecast To 2025 To Their Research Database

PUNE, INDIA, February 1, 2018 /EINPresswire.com/ — Global Clean Coal Technology Market

This report studies the global Clean Coal Technology market, analyzes and researches the Clean Coal Technology development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like 
Alstom Power 
Siemens AG 
General Electric 
KBR 
Shell 
ICCT 

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/2874071-global-clean-coal-technology-market-size-status-and-forecast-2025

Market segment by Regions/Countries, this report covers 
United States 
EU 
Japan 
China 
India 
Southeast Asia

Market segment by Application, Clean Coal Technology can be split into 
Coal Preparation 
Coal Burning 
Post-burning

Complete Report Details @ https://www.wiseguyreports.com/reports/2874071-global-clean-coal-technology-market-size-status-and-forecast-2025

Table of Contents-Key Points Covered

Global Clean Coal Technology Market Size, Status and Forecast 2025 
1 Industry Overview of Clean Coal Technology 
1.1 Clean Coal Technology Market Overview 
1.1.1 Clean Coal Technology Product Scope 
1.1.2 Market Status and Outlook 
1.2 Global Clean Coal Technology Market Size and Analysis by Regions (2013-2018) 
1.2.1 United States 
1.2.2 EU 
1.2.3 Japan 
1.2.4 China 
1.2.5 India 
1.2.6 Southeast Asia 
1.3 Clean Coal Technology Market by End Users/Application 
1.3.1 Coal Preparation 
1.3.2 Coal Burning 
1.3.3 Post-burning

2 Global Clean Coal Technology Competition Analysis by Players 
2.1 Clean Coal Technology Market Size (Value) by Players (2013-2018) 
2.2 Competitive Status and Trend 
2.2.1 Market Concentration Rate 
2.2.2 Product/Service Differences 
2.2.3 New Entrants 
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles 
3.1 Alstom Power 
3.1.1 Company Profile 
3.1.2 Main Business/Business Overview 
3.1.3 Products, Services and Solutions 
3.1.4 Clean Coal Technology Revenue (Million USD) (2013-2018) 
3.1.5 Recent Developments 
3.2 Siemens AG 
3.2.1 Company Profile 
3.2.2 Main Business/Business Overview 
3.2.3 Products, Services and Solutions 
3.2.4 Clean Coal Technology Revenue (Million USD) (2013-2018) 
3.2.5 Recent Developments 
3.3 General Electric 
3.3.1 Company Profile 
3.3.2 Main Business/Business Overview 
3.3.3 Products, Services and Solutions 
3.3.4 Clean Coal Technology Revenue (Million USD) (2013-2018) 
3.3.5 Recent Developments 
3.4 KBR 
3.4.1 Company Profile 
3.4.2 Main Business/Business Overview 
3.4.3 Products, Services and Solutions 
3.4.4 Clean Coal Technology Revenue (Million USD) (2013-2018) 
3.4.5 Recent Developments 
3.5 Shell 
3.5.1 Company Profile 
3.5.2 Main Business/Business Overview 
3.5.3 Products, Services and Solutions 
3.5.4 Clean Coal Technology Revenue (Million USD) (2013-2018) 
3.5.5 Recent Developments 
3.6 ICCT 
3.6.1 Company Profile 
3.6.2 Main Business/Business Overview 
3.6.3 Products, Services and Solutions 
3.6.4 Clean Coal Technology Revenue (Million USD) (2013-2018) 
3.6.5 Recent Developments

Continued….
      

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Rosanne Hanley to give out free dental needs to 3 people

Rosanne Hanley

Rosanne Hanley

Proper dental care is imperative in maintaining a healthy smile.

SARASOTA, FLORIDA, UNITED STATES, January 31, 2018 /EINPresswire.com/ — With the cost of both routine and cosmetic dentistry rising every year, Rosanne Hanley has stepped forward to help.

Social activist Hanley is looking to sponsor a round of dental care for 3 individuals who may otherwise be unable to afford the treatment or care they need.

The Florida-based fundraiser said of the idea, "A healthy, happy smile is worth a thousand words, but it occurred to me recently that not everyone has the luxury of access to quality dental care."

She continued, "Even routine check-ups can be expensive, while corrective and emergency procedures can cost thousands upon thousands of dollars."

By sponsoring three local individuals, keen volleyball player Hanley hopes she can make a real difference to their happiness and well-being.

"I want to literally put a smile on someone's face!" says an excited Hanley.

A recent study of dentistry prices in the US revealed that the national average cost of a dental exam is now $275 without insurance. This includes an oral exam, basic cleaning, and any necessary X-rays. In more expensive areas, the same visit can cost upwards of $500.

Many dental check-ups call for further treatment, which is where costs can really begin to mount.

The same report revealed that on average, a large filling now costs in excess of $170, while a tooth extraction will set a patient back $280.

Meanwhile, a root canal and bridge both cost over $680 on average, while a crown is likely to cost anywhere from $600-$1,200 depending on the material used.

A necessity for many older patients, denture prices start from $420 on average, while dental implants cost from $1,900 per tooth.

Rosanne Hanley appreciates that these costs are out of reach for many people.

"If you're not insured, visiting the dentist can become impossible due to the costs involved," she says.

"I hate the thought of anyone being in pain or otherwise unhappy because they cannot afford even simple attention from a dentist."

Hanley is hopeful that others will follow in her footsteps by sponsoring dental care for people less fortunate in their area.

"It's about giving something back to your local community," says Hanley. "I like to think that if I was in need, my friends and neighbors would reach out with help. That's the mindset I'm trying to foster in people everywhere!"

Eric Ash
Web Presence, LLC
941-266-8620
email us here


Source: EIN Presswire

PUERTO RICO ANNOUNCES MAJOR TOURISM MILESTONES WHILE HOSTING THE LARGEST AND MOST IMPORTANT REGIONAL TOURISM EVENT

PRTC

Air access growth is coming back at full capacity faster than comparable destinations
New and revamped $1.9 billion lodging develom to generate 3,500 new jobs

We have made great strides because we’ve implemented a comprehensive strategy which has in turn secured a promising comeback for the Island.”

— Carla Campos, Acting Executive Director of the PRTC

SAN JUAN, PR, UNITED STATES, January 31, 2018 /EINPresswire.com/ — SAN JUAN, Puerto Rico, Jan. 31, 2018 – The Puerto Rico Tourism Company (PRTC) announced today its rapid-pace recovery efforts and a positive outlook for 2018. What better occasion than at the 15th edition of the Caribbean Travel Marketplace, the most important regional tourism event of the Caribbean, and particularly meaningful this year, with Puerto Rico as host destination. This reaffirms Puerto Rico’s readiness to host visitors from all over the world.

“We have made great strides because we’ve implemented a comprehensive strategy which has, in turn, secured a promising comeback for the Island,” expressed Carla Campos, Acting Executive Director of the PRTC. “Puerto Rico has reached great milestones that couldn’t have been achieved without Governor Ricardo Rosselló’s leadership and the immense support we’ve received from travel industry private sector partners since day one. With over 1.9 billion dollars of hospitality development in the pipeline and an existing lodging inventory undergoing exciting renovations, Puerto Rico’s revamping is underway.”
Major milestones important for leisure and business travelers include:

• Cruises: Not only did Puerto Rico resume operations just two and a half weeks after Hurricane Maria, but by end of June, 2018, Puerto Rico will have received 1.04 million passengers. This Winter season, 14 vessels – four more than the previous season – are homeporting in San Juan, including Royal Caribbean Freedom of the Seas, the Windstar Pride, Silverseas Silver Wind and Viking Sea. The 2018/2019 cruising season is set to witness a record-breaking 1.7 million passengers, which is expected to generate roughly $250 million in revenue for the economy.

• Air Access: The airline industry is rapidly restoring and growing. Two weeks after Hurricane Maria, the Luis Muñoz Marin International Airport had 20 daily flights, but today, there are on average 110 daily flights. Capacity is on the rise with a current monthly seat volume of 391,000. By July 2018, seat capacity will increase by 81,000 more. Very promising is that by early summer 2018, air access will be on par with levels this time last year, and Puerto Rico is growing at a faster pace than comparable destinations that have gone through similar situations. Growth is driven by newly established routes and existing frequency, in addition to larger aircrafts that will result in higher seat capacity.

• Hotels: Currently, there are over 122 hotels operating, which equates to 12,458 available rooms. An exciting 2,670 more rooms will be added to that inventory after undergoing renovations. For example, the Wyndham Grand Rio Mar Puerto Rico Golf & Beach Resort, the Ritz-Carlton Reserve and El San Juan Hotel. Looking ahead, the Puerto Rico Tourism Company estimates 25% more rooms in the pipeline for development, which equates to 3,800 new rooms. Some of the hotels in the pipeline are the JW Marriott, Aloft San Juan Convention Center, Aloft Ponce, Serafina Hotel, Four Seasons Cayo Largo, among others. Approximately $1.9 billion will be injected into new developments and renovations, which contributes to adding roughly 3,831 new jobs.

• Destination Attractions: A month after Hurricane Maria, the Puerto Rico Tourism Company announced that 22 attractions were open, however, today there are more than 120. Additionally, 13 golf courses and 15 casinos are also open for recreation. Travelers need not worry about being hungry while on the Island because Puerto Rico has 4,000 operating restaurants. We are seeing continued commitment from partners who are choosing to keep their big-ticket events in Puerto Rico, like the DIVAS Half Marathon and 5K, PGA, Ironman, and MLB Series, all events happening in Q1 and Q2 of this year alone.

The PRTC is proud to announce significant milestones achieved by implementing fact and case study based planning based on destination management principles and strong partnerships with the public and private sectors whom have demonstrated increased commitment and confidence in Puerto Rico’s comeback. Instilling a forward-thinking approach that allows the destination to be more innovative in reaching its goals and identifying where our investments will give us the biggest return are instrumental pillars of the Puerto Rico Tourism Company Destination Recovery Strategy.

If planning a vacation is on the horizon, Puerto Rico wants to set the record straight. For more information including details on open attractions, accommodations, Puerto Rico's most popular restaurants and more, visit SeePuertoRico.com. And, for information on other Island updates (related to hospitals, ATMs, supermarkets, etc.), visit http://status.pr/. With the Island officially Open for Business, there is no better time to visit Puerto Rico.

Summarize of key developments:
Air access growth is coming back at full capacity faster than comparable destinations
New and revamped $1.9 billion lodging developments in the pipeline to generate 3,500 new jobs
Puerto Rico cruise ports expect to break cruise passenger records in upcoming season with 1.7 million visitors
Big brands continue to show their undeniable commitment by hosting premiere events

About Puerto Rico Tourism Company
The Puerto Rico Tourism Company (PRTC), founded in 1970, is a public corporation responsible for stimulating, promoting and regulating the development of the tourism industry. It markets Puerto Rico as a tourism destination through advertising, public relations and promotional activities; promotes tourism among visitors and local residents; provides visitor orientation and technical assistance to investors; evaluates tourism facilities and establishes standards of quality; and regulates and oversees gaming operations. PRTC has offices and representatives in the U.S. mainland, Canada, Europe and Latin America.

Carmen Pineiro
Ketchum
+1 646 935 4311
email us here


Source: EIN Presswire

Global Gene Therapy Market Expected to Reach $4,300 Million by 2021: Polaris Market Research

The Rising demand of the personalized treatments and need for the one stop cure for the rare indications and niche segments of the disease has led to the emergence of the gene therapies.”

— Polaris Market Research

BROOKLYN, NY, UNITED STATES, January 31, 2018 /EINPresswire.com/ — The Global Gene Therapy market size is expected to reach USD 4,300 million market by 2021 as reported by Polaris Market Research.

The Rising demand of the personalized treatments and need for the one stop cure for the rare indications and niche segments of the disease has led to the emergence of the gene therapies as a therapy option for the critical and deadly indications. The positive attitude of regulatory bodies has also created a favorable environment for the research and development in these therapies.

As of January 2018, there are 3000+ Reported Clinical Trials for Gene therapies, out of which 500+ trials are currently ongoing. The increase in the government funds for the research and development also paving the way for the secure future of gene therapies in coming time.

Polaris Market Research expects that with the expected launch of the potential gene therapies, the market is expected to rise at a higher pace. The Unites States accounts for the higher share of the market as compared to the Europe and Japan. The highest market size is subjected to the approval of KYMRIAH (Novartis), YESCARTA (Kite Pharmaceuticals) and LUXTURNA (Spark Therapeutics) and associated premium pricing.

Currently the Gene Therapy market is highly fragmented but with the current initiatives taken by the government and fastened approval process in developed countries, the market is soon going to be regulated.

The only restrain to the Gene Therapy market is premium pricing of the therapies. Polaris Market Research believes that the affordability of gene therapy is one of the primary concern in the mature markets. GlaxoSmithKline recently in October 2017 launched the gene therapy, STRIMVELIS for the ultra-rare disorder i.e. Severe Combined Immunodeficiency due to Adenosine Deaminase deficiency (AD-SCID) This drug comes with the price tag of $665,000 which makes it THE expensive drug in the entire gene therapy segment. The drug also comes with money back guarantee as reported by the company itself.

Polaris Market Research has provided the forecasts of the Global Gene Therapy Market from 2016-2021.

The major segments which has been investigated in the global market from 2016-2021 are:

1. Market Analysis by Marketed Gene Therapies
2. Market Analysis by Companies
3. Market Analysis by Indications

The Marketed Therapies undertaken in forecast from 2016-2021 are:

1. Rexin-G (Epeius Biotechnologies Corporation)
2. Gendicine (SiBiono GeneTech Co., Ltd)
3. Neovasculgen [Human Stem Cells Institute (HSCI))
4. Glybera (UniQure Biopharma B.V.)
5. KYMRIAH (Novartis)
6. YESCARTA (Kite Pharmaceuticals)
7. LUXTURNA (Spark Therapeutics)
8. STRIMVELIS (GlaxoSmithKline)

The Major Indications in Gene Therapy are:
1. Cancer
2. Neurodegenerative Disorders
3. Lysosomal Storage Disorders (LSDs)
4. Ocular Diseases
5. Muscle Disorders
6. Anemia
7. Hemophilia
8. Severe Combined Immunodeficiency due to Adenosine Deaminase deficiency

Leading Companies investigated in the Report are

1. Novartis Pharmaceuticals Corporation
2. Kite Pharma, Incorporated
3. Spark Therapeutics, Inc
4. GlaxoSmithKline
5. Adaptimmune
6. Bluebird bio
7. Celgene
8. Shanghai Sunway Biotech
9. Shenzhen SiBiono GeneTech
10. SynerGene Therapeutics
11. Others

Browse other reports by Polaris Market Research:
https://www.polarismarketresearch.com/industry/Healthcare/

Neel
Polaris Market Research & Consulting
+16465689980
email us here


Source: EIN Presswire

Global Games Market 2018 Size, Share, Growth, Trends, Type, Application and Forecast by 2022

WiseGuyReports.com adds “Games Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2025”reports to its database.

PUNE, INDIA, January 31, 2018 /EINPresswire.com/ — Games Market:

Executive Summary

This report studies Games in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

Tencent
Microsoft
Sony
Activision Blizzard
Apple
EA
Google
NetEase
Warner Bros
King
Nintendo
Nexon
Mixi
TakeTwo Interactive
GungHo Entertainment
Square Enix
Disney
Ubisoft
Konami
DeNA

Request Sample Report @ https://www.wiseguyreports.com/sample-request/2739262-global-games-market-professional-survey-report-2017

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Online Games
Offline Games
Others

By Application, the market can be split into

PC
Console
Smartphone
Tablet
Handheld
Others

By Regions, this report covers (we can add the regions/countries as you want)

North America
China
Europe
Southeast Asia
Japan
India

If you have any special requirements, please let us know and we will offer you the report as you want.

For further information on this report, visit – https://www.wiseguyreports.com/enquiry/2739262-global-games-market-professional-survey-report-2017

Table of content:

Global Games Market Professional Survey Report 2017
1 Industry Overview of Games
1.1 Definition and Specifications of Games
1.1.1 Definition of Games
1.1.2 Specifications of Games
1.2 Classification of Games
1.2.1 Online Games
1.2.2 Offline Games
1.2.3 Others
1.3 Applications of Games
1.3.1 PC
1.3.2 Console
1.3.3 Smartphone
1.3.4 Tablet
1.3.5 Handheld
1.3.6 Others
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India

2 Manufacturing Cost Structure Analysis of Games
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Games
2.3 Manufacturing Process Analysis of Games
2.4 Industry Chain Structure of Games

3 Technical Data and Manufacturing Plants Analysis of Games
3.1 Capacity and Commercial Production Date of Global Games Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Games Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Games Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Games Major Manufacturers in 2016

4 Global Games Overall Market Overview
4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2012-2017E Global Games Capacity and Growth Rate Analysis
4.2.2 2016 Games Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2012-2017E Global Games Sales and Growth Rate Analysis
4.3.2 2016 Games Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2012-2017E Global Games Sales Price
4.4.2 2016 Games Sales Price Analysis (Company Segment)

5 Games Regional Market Analysis
5.1 North America Games Market Analysis
5.1.1 North America Games Market Overview
5.1.2 North America 2012-2017E Games Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2012-2017E Games Sales Price Analysis
5.1.4 North America 2016 Games Market Share Analysis
5.2 China Games Market Analysis
5.2.1 China Games Market Overview
5.2.2 China 2012-2017E Games Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2012-2017E Games Sales Price Analysis
5.2.4 China 2016 Games Market Share Analysis
5.3 Europe Games Market Analysis
5.3.1 Europe Games Market Overview
5.3.2 Europe 2012-2017E Games Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2012-2017E Games Sales Price Analysis
5.3.4 Europe 2016 Games Market Share Analysis
5.4 Southeast Asia Games Market Analysis
5.4.1 Southeast Asia Games Market Overview
5.4.2 Southeast Asia 2012-2017E Games Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2012-2017E Games Sales Price Analysis
5.4.4 Southeast Asia 2016 Games Market Share Analysis
5.5 Japan Games Market Analysis
5.5.1 Japan Games Market Overview
5.5.2 Japan 2012-2017E Games Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2012-2017E Games Sales Price Analysis
5.5.4 Japan 2016 Games Market Share Analysis
5.6 India Games Market Analysis
5.6.1 India Games Market Overview
5.6.2 India 2012-2017E Games Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2012-2017E Games Sales Price Analysis
5.6.4 India 2016 Games Market Share Analysis

6 Global 2012-2017E Games Segment Market Analysis (by Type)
6.1 Global 2012-2017E Games Sales by Type
6.2 Different Types of Games Product Interview Price Analysis
6.3 Different Types of Games Product Driving Factors Analysis
6.3.1 Online Games of Games Growth Driving Factor Analysis
6.3.2 Offline Games of Games Growth Driving Factor Analysis
6.3.3 Others of Games Growth Driving Factor Analysis

7 Global 2012-2017E Games Segment Market Analysis (by Application)
7.1 Global 2012-2017E Games Consumption by Application
7.2 Different Application of Games Product Interview Price Analysis
7.3 Different Application of Games Product Driving Factors Analysis
7.3.1 PC of Games Growth Driving Factor Analysis
7.3.2 Console of Games Growth Driving Factor Analysis
7.3.3 Smartphone of Games Growth Driving Factor Analysis
7.3.4 Tablet of Games Growth Driving Factor Analysis
7.3.5 Handheld of Games Growth Driving Factor Analysis
7.3.6 Others of Games Growth Driving Factor Analysis

Continuous…

Buy this Report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2739262

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

AMERICAN GENE TECHNOLOGIES ANNOUNCES PROGRESS TOWARD PHASE I CLINICAL TRIAL OF AGT103-T FOR HIV FUNCTIONAL CURE

Completes process development for the AGT103-T automated cell manufacturing protocol

ROCKVILLE, MD, USA, January 31, 2018 /EINPresswire.com/ — American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company, today announced completion of the pilot runs of its HIV Functional Cure automated cell processing protocol. This completes a key milestone of AGT’s planned Phase I clinical trial of AGT103-T, a genetically modified autologous T cell product in development as an HIV functional cure.

“This accomplishes the second of two key developments that prepare AGT for an IND submission,” said David Pauza, Ph.D., AGT’s Chief Science Officer. “We have now produced a GMP-grade lentiviral vector stock that will modify HIV-specific T cells to make them immune to HIV entry and depletion. We fully developed the process for treating cells, in an automated unit, which reliably manufactures the cell product. The results from the most recent pilot run were nearly four times the level that we believe is necessary to restore HIV immunity in HIV-positive individuals.”

The devastating impact of HIV/AIDS was dramatically relieved due to the development and global distribution of antiretroviral drugs. While these drugs marked a landmark achievement for medicine, even decades of treatment do not cure HIV and the virus re-emerges within just a few weeks off therapy. AGT103-T is the result of advances in genetic research to develop an immunotherapeutic that will potentially create a functional cure by reconstituting each person’s immunity to HIV disease. The approach taken by AGT differs substantially from other companies’ strategies by focusing on HIV-specific immune cells responsible for building and maintaining strong immunity against the virus. AGT’s product protects these HIV-specific immune cells through genetic modifications that knock down CCR5, a key surface protein utilized by HIV, and prevents replication of HIV already resident in those T cells. AGT’s cell therapy is expected to enable HIV-infected individuals to control and eliminate their viremia over time without the need for lifelong antiretroviral chemotherapy, render them non-contagious, protect them from developing AIDS, and provide immunity to reinfection for life.

Jeff Galvin, Chief Executive Officer, added, “This product is the most complex cell therapy the industry has delivered to date, and is a further indication of the sophistication, depth and breadth of AGT’s gene technology platform for drug development. We hope to show efficacy for our HIV treatment this year and add several infectious disease therapeutics to our pipeline in 2019, while continuing to develop our monogenic disease portfolio and our gamma delta T cell immuno-oncology programs.”

American Gene Technologies

AGT is an emerging gene and cell therapeutics company with a proprietary lentiviral platform capable of broad applications including large and orphan indications, infectious disease, immune-oncology, and monogenic disorders. AGT expects to take its lead candidate for an HIV functional cure into the clinic in 2018 and is pioneering a novel immuno-oncology approach of stimulating gamma-delta (γδ) T cells to attack multiple cancers. AGT has a diverse portfolio of patent filings surrounding key tools and components in viral vectors, gene therapy, and regenerative medicine, and a key patent in AGT's novel immuno-oncology approach has already been granted. AGT has developed a modified gene (patent-pending) able to express therapeutic levels of phenylalanine hydroxylase (PAH) that it is deploying, along with other proprietary AGT technologies, in pursuit of a cure for Phenylketonuria (PKU). AGT expects to begin clinical activities for PKU in 2019, and for liver cancer (AGT's first immuno-oncology therapy) in 2020.

More information can be found at www.americangene.com.

American Gene Technologies Contact:
C. Neil Lyons, Chief Financial Officer
Phone: (301) 337-2269
Email: info@americangene.com

Media Contact:
Cari P. Randall, Vice President
The Ruth Group
Phone: (646) 536-7002
Email: crandall@theruthgroup.com

Investor Contact:
Robert E. Flamm, Ph.D., Senior Vice President
The Ruth Group
Phone: (646) 536-7017
Email: rflamm@theruthgroup.com

Sasha Whitaker
American Gene Technologies International Inc.
2029972626
email us here


Source: EIN Presswire

IT Governance launches ISO 27001 webinar series to support organizations with ISMS implementation

IT Governance, the global cybersecurity experts.

NEW YORK, UNITED STATES, January 31, 2018 /EINPresswire.com/ — IT Governance, the leading provider of information security and General Data Protection Regulation (GDPR) expertise and training, and a globally recognized authority on ISO 27001, is delighted to announce the launch of new webinars on ISO 27001 compliance.

As the number of cyber attacks continues to rise and data security laws and regulations become more stringent, businesses are under increasing pressure to protect their systems from cyber attacks, slip-ups, and data misuse. But the challenge of complying with multiple cybersecurity regulations is considerable. With little guidance on how to achieve a robust data security posture, organizations are struggling to find a comprehensive solution that can assure compliance.

ISO/IEC 27001:2013 (ISO 27001) is the international standard that describes best practice for an information security management system (ISMS). Achieving accredited certification to ISO 27001 demonstrates that your company is following information security best practice, and provides an independent, expert verification that information security is being managed in line with international best practice and business objectives.

IT Governance’s free new webinars will share valuable insight into information security problem-solving. The first webinar aims to provide an overview of the current cybersecurity landscape and the latest data protection laws, and to highlight how an ISMS can help create the best strategies to mitigate breaches and meet even the most stringent of compliance standards.

Alan Calder, the founder and executive chairman of IT Governance, said: “New York financial organizations can not only meet the New York State Department of Financial Services (NYDFS) requirements but also ensure they are prepared in an ever-changing cybersecurity landscape by implementing ISO 27001, the internationally recognized information security management standard.

“The aim of our new ISO 27001 webinars is to introduce the Standard and its implementation step by step, as well as to prepare organizations for their toughest data security challenges yet.”

The first webinar, How to overcome your data security compliance challenges, goes live on February 15 at 10:00 am (EST)/1:00 pm (PST). It will be followed by:

– How to implement an information security management system
– Conducting a cybersecurity risk assessment
– Assessing compliance: the ISO 27001 ISMS internal audit

To read more about each webinar, please visit our webinar page. To discuss your cybersecurity requirements, contact our consultancy team at servicecenter@itgovernanceusa.com, or request a call.

Mihaela Jucan
IT Governance Ltd
00443338007000
email us here


Source: EIN Presswire

The First Belt & Road International Food Expo (Hong Kong) Seeks to Provide New Opportunities for Food Industries

BRIFE 2018

Steering World Food Industries to New Opportunities

HONG KONG, HONG KONG, HONG KONG, January 31, 2018 /EINPresswire.com/ — The Belt and Road Initiative (BRI) provides a visionary blueprint for global economy in the 21st century, brings new opportunities to promote prosperity and development of emerging countries and economies along the scheme.

Under the theme of “Steering World Food Industries to New Opportunities”, the First Belt & Road International Food Expo (Hong Kong) (BRIFE 2018) will take place from June 27 to June 29, 2018 in AsiaWord-Expo, Hong Kong. It aims to facilitate trade and provide an international platform for buyers, sellers and service providers of food industry to come together and explore opportunities. Five halls of separate specialties, will be an opportune occasion for procuring, business matching and providing professional business solutions.

Major supporters of BRIFE 2018 includes: Invest Hong Kong (the Government of the HKSAR), Meetings & Exhibitions Hong Kong (A Division of Hong Kong Tourism Board) and the Belt & Road Global Development Alliance. Apart from the 3-day trade show, BRIFE 2018 will also host remarkable events: The First Belt and Road Agrifood & Trade Summit (ATS)”and “2018 Belt & Road Hot Chef Culinary Challenge”.

ATS on June 27 this year will be a high-level event which is highlighted with multiple distinguished guests such as country ministers of agriculture and trade, business leaders, ambassadors, consul-generals, industry experts, international investors and professional services providers etc. Providing a solid platform for business matching and investment promotion.

Aims at promoting different cuisine culture from over 73 Belt & Road countries & regions and worldwide, enhancing industry communication and public knowledge, the 2018 Belt & Road Hot Chef Culinary Challenge (June 27-29, 2018) will bring together over 100 elite chefs globally and compete with different types of cuisine cooking under the “Hot & Spicy” theme.

12 Consul-Generals in Hong Kong, 4 countries’ Ambassadors to the PRC and 15 prestigious personages & community key leaders forms our Honorary Advisory Board. The Expo will provide 1,200 booths, exhibitors and buyers from over 35 countries and regions will participate.

Please visit https://brifexpo.com/ for details.

About FMC Exhibition Co. Limited
FMC Exhibition Co. Limited, aims to provide professional exhibition planning services and organize large-scale international exhibitions and conferences.

BRIFE 2018
Fmc Exhibition Co Limited
852 2370 0829
email us here


Source: EIN Presswire

Global Bio-Based Polyethylene Terephthalate Market to Surpass US$ 7.1 Billion by 2025

Coherent Market Insights

Coherent Market Insights

Global Bio-Based Polyethylene Terephthalate Market Fuelled by Rising Initiatives Taken by Regulating Bodies to Reduce Greenhouse Emissions

SEATTLE, WASHINGTON, UNITED STATES, January 31, 2018 /EINPresswire.com/ — The Bio-Based Polyethylene Terephthalate market was valued at US$ 1,883.5 Million in 2016, according to Bio-Based Polyethylene Terephthalate Market, by Application (Bottles, Bags, 3D Printing, Foils and Fibers, Carpets and Others), By End-Use Industry (Packaging, Automotive, Textile and Others), published by Coherent Market Insights. The bio-based polyethylene terephthalate market is projected to reach US$ 7,116.3 Million by 2025, exhibiting a CAGR of 16.1% during the forecast period.

Rising initiatives taken up by the regulating bodies in the adoption of sustainable packaging to reduce carbon footprint combined with increasing research and development activities for manufacturing of 100% bio-based polyethylene terephthalate bottles is one of the major factors driving growth of the market. For instance, The Coca Cola Company developed the first 100% bio-based polyethylene terephthalate (PET) bottle in 2015, based on technology developed by biofuels and biochemical company Virent Inc. Moreover, increasing use of bio-based PET in the automotive sector due to the lightweight and environment friendly qualities, is expected to boost the demand for the same further.

Request Sample copy of Report@ https://www.coherentmarketinsights.com/insight/request-sample/1254

Key Trends and Analysis of the Bio-Based Polyethylene Terephthalate Market:

Based on application bio-based polyethylene terephthalate market is segmented into bottles, bags, 3D printing, foils & fibers, carpets and others. Bottles accounted for the largest market share in 2016 and the same is expected to retain market dominance throughout the forecast period. Rising demand for beverages coupled with government participation for reduction of greenhouse emissions and stringent regulations are some of the major factors boosting the demand for Bio-Based PET market. For instance, post completion of the of the Lead Market Initiative, the European Commission established an Expert Group for Bio-based Products in 2013 in line with the commission’s Bioeconomy Strategy. The strategy majorly focused on shifting the European economy towards the usage of renewable resources and the development of bio-based product sector by increasing the conversion of waste streams into value-added products.

Key Takeaways of the Market:

Asia Pacific held a dominant position in the global bio-based polyethylene terephthalate market and is projected to exhibit a CAGR of 17.8% during the forecast period. Steadily increasing consumption of alcoholic beverages and carbonated soft drinks in the region is also expected to boost the growth of the bio-based polyethylene terephthalate market in the region. According to the Economic and Social Commission for Asia and the Pacific (ESCAP), in 2014, North and Central Asia accounted for the highest volume of alcohol consumption which was close the total volume consumption of alcohol in Europe. Further, according to the Thailand Board of Investment, Thailand holds the major growth opportunity for bio plastic industry, as Thailand has a flourishing agricultural sector in products including cassava, rice and sugarcane. Thailand’s large agricultural base is projected to be used as a biomass feedstock for bio plastics.

In addition, Thai government along with the National Innovation Agency (NIA), worked on various supporting programs such as establishment of the Thai Bioplastics Industry Association (TBIA). TBIA was founded in 2007, which assists bio plastic firms to reach international standards by certification and laboratory testing. These are the factors propelling the market growth of bio-based PET in the region.

Europe was the second largest region in the global bio-based polyethylene terephthalate market in 2016 and is expected to retain its position during the forecast period. Growing environmental awareness is expected to propel the demand for bio-based PET over petroleum-based plastics in the region. Further, according to the European Biomass Industry Association (EUBIA), rising food and beverage industry in Germany, UK and France is expected to boost the market for bio-based PET in those countries. According to Plastics Europe, bio-based plastics such as Bio-PET and bio-PE are majorly used in packaging. These are the factors, largely supporting the market growth of bio-based polyethylene terephthalate in Europe.

To know the latest trends and insights prevalent in this market, click the link below:
https://www.coherentmarketinsights.com/market-insight/bio-based-polyethylene-terephthalate-market-1254

Browse 150 market data tables* and 90 figures* on "Bio-Based Polyethylene Terephthalate Market” – Global forecast to 2025.

The major players operating in the global bio-based polyethylene terephthalate market include, Toray Industries Inc., The Coca-Cola Company, Teijin Limited, Toyota Tsusho Corporation, Anellotech Inc., Gevo Inc., Plastipak Holdings Inc., Virent Inc. and Ford Motor Company.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Website: http://www.coherentchronicle.com/

Mr. Shah
Coherent Market Insights
+1-206-701-6702
email us here


Source: EIN Presswire

Immuno-Oncology (IO)-Competitive Analysis and Market Forecast- [2016-2022]- Report by Polaris Market Research

The growth in the biopharmaceutical industry is predominantly being driven by oncology products which was roughly ~94 Billion USD in 2016”

— Polaris Market Research

BROOKLYN, NY, UNITED STATES, January 31, 2018 /EINPresswire.com/ — The Global Oncology market size is expected to exceed USD 190 billion by 2022. The Immuno-Oncology market was valued at USD 6 billion representing 7% of the global Oncology market in 2016 but is expected to grow at a impressive CAGR of ~30% during the forecast period from 2016-2022 as reported by Polaris Market Research.

The immune-checkpoint blockade, is the revolutionizing treatment options in almost all oncology disease areas which has witnessed the rapid uptake in the growing Oncology market. These therapies are largely dependent on the global immune system of each individual patient, and not necessarily dependent only on the tumor biology which makes it the truly personalized medicine.

As of December 2017, there are 6 Immuno-Oncology therapies which have been launched in the market, with the Opdivo and Keytruda being the highest sales generating drugs. There are dozens of targets being tested across hundreds of clinical trials ongoing for Cancer therapy area as a monotherapy and as combination trials.

Polaris Market Research estimates that with the expected launch of the potential Immuno-Oncology, the market is expected grow at a higher rate. The Unites States accounts for the higher share of the market as compared to the Europe and Japan. The highest market size is subjected to the growth of the two immunotherapies ie Keytruda (Merck) and Opdivo (Bristol Myers Squibb), expansion of these therapies in other cancers and rapid uptake of overall immunotherapies.

On the flip side, with the approval of the immunotherapies, the complexity of cancer treatment in patients as a personalized medicine has also increased. These therapies are thought to be largely dependent on the global immune system of each individual patient, and not necessarily dependent only on the tumor biology. Even the target-specific molecular characteristics of a tumor are only present in a small proportion of patients which are to be cured by immunotherapies. Therefore, new technologies are needed that can help predict which patients will benefit from immunotherapy.

Polaris Market Research has provided the forecasts of the Global Immuno-Oncology Therapies Market from 2016-2022.

The major segments which has been investigated in the global market from 2016-2022 are:

1. Market Analysis by Marketed Immuno-Oncology Therapies
2. Market Analysis by Companies
3. Market Analysis by Indications

The Marketed Therapies undertaken in forecast from 2016-2022 are:

1. Yervoy (Bristol Myers Squibb)
2. Keytruda (Merck)
3. Opdivo (Bristol Myers Squibb)
4. Tecentriq (Roche)
5. Bavencio (Merck/Pfizer)
6. Imfinzi (AstraZeneca)
7. Epacadostat (Incyte Pharmaceuticals)
8. Tremelimumab (AstraZeneca)

The Major Indications in Immuno-Oncology Therapies are:

1. Melanoma
2. Lung Cancer
3. Small Cell Lung Cancer (SCLC)
4. Non-Small Cell Lung Cancer (NSCLC)
5. Head & Neck Squamous Cell Carcinoma (HNSCC)
6. Renal Cell Cancer
7. Bladder Cancer

Leading Companies investigated in the Report are

1. Bristol Myers Squib (BMS)
2. Merck (MRK)
3. AstraZeneca (AZ)
4. Bristol Myers Squib (BMS)
5. Roche Holding AG (RHHBY)
6. Pfizer (PFE)
7. Incyte (INCY)
8. Other Companies

Browse other reports by Polaris Market Research:
https://www.polarismarketresearch.com/industry/Healthcare/

Neel
Polaris Market Research & Consulting
+16465689980
email us here


Source: EIN Presswire